Get startedLog in
    Picture of Johnson & Johnson logo

    JNJ — Johnson & Johnson News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: JNJ Reports Low Rates Of Treatment-Related Events For Rybrevant Faspro Plus Lazcluze At Wclc 2026

    Picture of Johnson & Johnson logoJohnson & Johnson
    15/09/2026 04:03
    BRIEF-JNJ Reports Low Rates Of Treatment-Related Events For Rybrevant Faspro Plus Lazcluze At Wclc 2026
    Sept 14 (Reuters) - Johnson & Johnson JNJ.N:
    • J&J - JNJ REPORTS LOW RATES OF TREATMENT-RELATED EVENTS FOR RYBREVANT FASPRO PLUS LAZCLUZE AT WCLC 2026
    • J&J - FEWER THAN 1% DISCONTINUE RYBREVANT FASPRO PLUS LAZCLUZE DUE TO TREATMENT-RELATED EVENTS AT ONE YEAR
    Source text: [ID:]
    Further company coverage: JNJ.N

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Johnson & Johnson

    See all news